ID

42640

Description

A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00744991

Lien

https://clinicaltrials.gov/show/NCT00744991

Mots-clés

Versions (2)
  1. 05/02/2018 05/02/2018 -
  2. 17/09/2021 17/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

17 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

Anglais

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed mycosis fungoides or sezary syndrome
Description

Mycosis Fungoides | Sezary Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0026948
UMLS CUI [2]
C0036920
stage ib to ivb disease at screening
Description

Disease Ann Arbor lymphoma staging system

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0432516
recurrent or refractory disease after at least 1 prior systemic therapy
Description

Recurrent disease | Refractory Disease | Status post Systemic therapy Quantity

Type de données

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C1514815
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1515119
UMLS CUI [3,3]
C1265611
have adequate organ function defined as:
Description

Organ function

Type de données

boolean

Alias
UMLS CUI [1]
C0678852
at least 30 days must have passed since other treatment for ctcl.
Description

Therapeutic procedure Cutaneous T-Cell Lymphoma | Requirement Elapsed Time

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0079773
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C2826303
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
receiving concurrent treatment for ctcl
Description

Therapeutic procedure Cutaneous T-Cell Lymphoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0079773
unable to swallow tablets
Description

Lacking Able to swallow Tablets

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0039225
receiving high potency oral or topical steroids. low potency oral steroid may be permitted in patients who have been on a stable dose for at least 4 weeks prior to screening. oral or topical antihistamine is allowed.
Description

Steroids Oral High Potency | Topical steroids High Potency | Antihistamines Oral allowed | Topical antihistamine allowed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1656349
UMLS CUI [2,1]
C2064827
UMLS CUI [2,2]
C1656349
UMLS CUI [3,1]
C0019590
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0683607
UMLS CUI [4,1]
C0357949
UMLS CUI [4,2]
C0683607
unable to discontinue use of carbamazepine, phenobarbital, or phenytoin
Description

Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006949
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0031412
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0031507
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
have a serious concomitant systemic disorder or hiv
Description

HIV Infection Systemic Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0205404
have a serious cardiac condition such as myocardial infarction within past 6 months, angina, or heart disease as defined by the new york heart association (nyha) class iii or iv
Description

Cardiac problem Serious | Myocardial Infarction | Angina Pectoris | Heart Disease New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262402
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0002962
UMLS CUI [4,1]
C0018799
UMLS CUI [4,2]
C1275491
have ecg abnormalities,
Description

ECG abnormality

Type de données

boolean

Alias
UMLS CUI [1]
C0522055
are pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Cutaneous T-Cell Lymphoma NCT00744991

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Mycosis Fungoides | Sezary Syndrome
Item
histologically confirmed mycosis fungoides or sezary syndrome
boolean
C0026948 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
Disease Ann Arbor lymphoma staging system
Item
stage ib to ivb disease at screening
boolean
C0012634 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Recurrent disease | Refractory Disease | Status post Systemic therapy Quantity
Item
recurrent or refractory disease after at least 1 prior systemic therapy
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C1515119 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Organ function
Item
have adequate organ function defined as:
boolean
C0678852 (UMLS CUI [1])
Therapeutic procedure Cutaneous T-Cell Lymphoma | Requirement Elapsed Time
Item
at least 30 days must have passed since other treatment for ctcl.
boolean
C0087111 (UMLS CUI [1,1])
C0079773 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C2826303 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Cutaneous T-Cell Lymphoma
Item
receiving concurrent treatment for ctcl
boolean
C0087111 (UMLS CUI [1,1])
C0079773 (UMLS CUI [1,2])
Lacking Able to swallow Tablets
Item
unable to swallow tablets
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Steroids Oral High Potency | Topical steroids High Potency | Antihistamines Oral allowed | Topical antihistamine allowed
Item
receiving high potency oral or topical steroids. low potency oral steroid may be permitted in patients who have been on a stable dose for at least 4 weeks prior to screening. oral or topical antihistamine is allowed.
boolean
C0038317 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1656349 (UMLS CUI [1,3])
C2064827 (UMLS CUI [2,1])
C1656349 (UMLS CUI [2,2])
C0019590 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0683607 (UMLS CUI [3,3])
C0357949 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable
Item
unable to discontinue use of carbamazepine, phenobarbital, or phenytoin
boolean
C0006949 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0031412 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0031507 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
HIV Infection Systemic Serious
Item
have a serious concomitant systemic disorder or hiv
boolean
C0019693 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
Cardiac problem Serious | Myocardial Infarction | Angina Pectoris | Heart Disease New York Heart Association Classification
Item
have a serious cardiac condition such as myocardial infarction within past 6 months, angina, or heart disease as defined by the new york heart association (nyha) class iii or iv
boolean
C0262402 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2])
C0002962 (UMLS CUI [3])
C0018799 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
ECG abnormality
Item
have ecg abnormalities,
boolean
C0522055 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial